ULBI vs CBAT

For growth investors, Ultralife Corporation (ULBI) is the stronger pick with 3.

7% revenue growth year-over-year, versus -13. 6% for CBAK Energy Technology, Inc. (CBAT). CBAK Energy Technology, Inc. (CBAT) offers the better valuation at 6. 0x trailing P/E, making it the more compelling value choice. Analysts rate Ultralife Corporation (ULBI) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, CBAK Energy Technology, Inc.

(CBAT) is the cheapest at 6. 0x versus Ultralife Corporation at 18. 6x.

Over the past 5 years, Ultralife Corporation (ULBI) delivered a total return of -10.

0%, compared to -81. 0% for CBAK Energy Technology, Inc. (CBAT). Over 10 years, the gap is even starker: ULBI returned +71. 5% versus CBAT's -69. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), CBAK Energy Technology, Inc.

(CBAT) is the lower-risk stock at 1. 05β versus Ultralife Corporation's 1. 50β — meaning ULBI is approximately 43% more volatile than CBAT relative to the S&P 500. On balance sheet safety, CBAK Energy Technology, Inc. (CBAT) carries a lower debt/equity ratio of 25% versus 44% for Ultralife Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Ultralife Corporation (ULBI) is pulling ahead at 3.

7% versus -13. 6% for CBAK Energy Technology, Inc. (CBAT). On earnings-per-share growth, the picture is similar: CBAK Energy Technology, Inc. grew EPS 574. 5% year-over-year, compared to -13. 6% for Ultralife Corporation. Over a 3-year CAGR, CBAT leads at 49. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

CBAK Energy Technology, Inc.

(CBAT) is the more profitable company, earning 6. 7% net margin versus 3. 8% for Ultralife Corporation — meaning it keeps 6. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ULBI leads at 6. 1% versus 5. 0% for CBAT. At the gross margin level — before operating expenses — ULBI leads at 25. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, CBAK Energy Technology, Inc.

(CBAT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 05)). Both have compounded well over 10 years (CBAT: -69. 9%, ULBI: +71. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: ULBI is a small-cap quality compounder stock; CBAT is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.